{
    "code": "01041037",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01041037",
    "time": "2015-09-25 04:22:36",
    "許可證字號": "衛署藥製字第041037號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/09\/18",
    "發證日期": "87\/09\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104103702",
    "中文品名": "力得微脂體注射劑2毫克\/毫升（鹽酸杜薩魯比辛）",
    "英文品名": "LIPO-DOX LIPOSOME INJECTION 2MG\/ML(DOXORUBICIN HYDROCHLORIDE)",
    "適應症": "用於治療CD4數量低下(",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 5\/10公撮小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "DOXORUBICIN HYDROCHLORIDE(LIPOSOME)",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "1406801100  臺灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": {
        "製造廠名稱": "1406804300  臺灣東洋藥品工業股份有限公司中壢廠",
        "製造廠廠址": "桃園市中壢區中華路一段８３８號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000615",
            "成分名稱": "DOXORUBICIN HYDROCHLORIDE(LIPOSOME)",
            "含量描述": "(POTENCY)",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lipo-Dox_20120427_賦形劑變更(送件)___20120516.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041037&Seq=001&Type=9"
        }
    ]
}